AAAAAA
Results:
1-21
|
Results: 21
Authors:
DENG C
GOLUSZKO E
DEDHIA V
CHRISTADOSS P
Citation: C. Deng et al., FAS-MEDIATED APOPTOSIS IS ONE OF THE MECHANISMS OF HIGH-DOSE ACETYLCHOLINE-RECEPTOR T-CELL EPITOPE TOLERANCE IN EXPERIMENTAL MYASTHENIA-GRAVIS, The FASEB journal, 12(4), 1998, pp. 1809-1809
Authors:
DEDHIA V
GOLUSZKO E
WU B
DENG CS
CHRISTADOSS P
Citation: V. Dedhia et al., THE EFFECT OF B-CELL DEFICIENCY ON THE IMMUNE-RESPONSE TO ACETYLCHOLINE-RECEPTOR AND THE DEVELOPMENT OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS, Clinical immunology and immunopathology (Print), 87(3), 1998, pp. 266-275
Authors:
WU B
DENG CS
GOLUSZKO E
CHRISTADOSS P
Citation: B. Wu et al., TOLERANCE TO A DOMINANT T-CELL EPITOPE IN THE ACETYLCHOLINE-RECEPTOR MOLECULE INDUCES EPITOPE SPREAD AND SUPPRESSES MURINE MYASTHENIA-GRAVIS, The Journal of immunology, 159(6), 1997, pp. 3016-3023
Authors:
KAUL R
WU B
GOLUSZKO E
DENG CS
DEDHIA V
NABOZNY GH
DAVID CS
RIMM IJ
SHENOY M
HAQQI TM
CHRISTADOSS P
Citation: R. Kaul et al., EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS IN B10.BV8S2 TRANSGENIC MICE - PREFERENTIAL USAGE OF TCRAV1 GENE BY LYMPHOCYTES RESPONDING TO ACETYLCHOLINE-RECEPTOR, The Journal of immunology, 158(12), 1997, pp. 6006-6012
Authors:
DENG C
GOLUSZKO E
WU B
BARON S
DEDHIA V
CHRISTADOSS P
Citation: C. Deng et al., INTERFERON-ALPHA THERAPY FOR ESTABLISHED CLINICAL EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS INDUCES REMISSION, The FASEB journal, 10(6), 1996, pp. 152-152
Authors:
DEDHIA V
GOLUSZKO E
CHRISTADOSS P
Citation: V. Dedhia et al., ROLE OF CD8-CELLS IN THE PATHOGENESIS OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS (EAMG)( T), The FASEB journal, 10(6), 1996, pp. 1760-1760
Authors:
DENG CS
GOLUSZKO E
BARON S
WU B
CHRISTADOSS P
Citation: Cs. Deng et al., IFN-ALPHA THERAPY IS EFFECTIVE IN SUPPRESSING THE CLINICAL EXPERIMENTAL MYASTHENIA-GRAVIS, The Journal of immunology, 157(12), 1996, pp. 5675-5682
Authors:
CHRISTADOSS P
BARON S
SHENOY M
GOLUSZKO E
WU B
Citation: P. Christadoss et al., IMMUNOMODULATION OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS WITH INTERFERON-ALPHA, Journal of cellular biochemistry, 1995, pp. 138-138
Authors:
GOLUSZKO P
NOWICKI B
GOLUSZKO E
NOWICKI S
KAUL A
PHAM T
Citation: P. Goluszko et al., ASSOCIATION OF COLONY VARIATION IN SERRATIA-MARCESCENS WITH THE DIFFERENTIAL EXPRESSION OF PROTEASE AND TYPE-1 FIMBRIAE, FEMS microbiology letters, 133(1-2), 1995, pp. 41-45
Authors:
WU B
SHENOY M
GOLUSZKO E
KAUL R
CHRISTADOSS P
Citation: B. Wu et al., TCR GENE USAGE IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS PATHOGENESIS - USAGE OF MULTIPLE TCRBV GENES IN THE H-2(B) STRAINS, The Journal of immunology, 154(7), 1995, pp. 3603-3610
Authors:
SHENOY M
BARON S
WU B
GOLUSZKO E
CHRISTADOSS P
Citation: M. Shenoy et al., IFN-ALPHA TREATMENT SUPPRESSES THE DEVELOPMENT OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS, The Journal of immunology, 154(11), 1995, pp. 6203-6208
Authors:
KAUL R
SHENOY M
GOLUSZKO E
CHRISTADOSS B
Citation: R. Kaul et al., MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENE DISRUPTION PREVENTS EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS+, Journal of cellular biochemistry, 1994, pp. 317-317
Authors:
SHENOY M
KAUL R
GOLUSZKO E
DAVID C
CHRISTADOSS P
Citation: M. Shenoy et al., MHC CLASS-I RESTRICTED CD8(-CELLS ARE NOT THE EFFECTORS DURING THE INDUCTION OF AUTOIMMUNE MYASTHENIA-GRAVIS IN C57BL10 MICE() T), Journal of cellular biochemistry, 1994, pp. 320-320
Authors:
BO W
SHENOY M
GOLUSZKO E
KAUL R
CHRISTADOSS P
Citation: W. Bo et al., POSSIBLE REGULATOR SUPPRESSOR ROLE OF TCR-V-BETA(-GRAVIS() CELLS IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA), Journal of cellular biochemistry, 1994, pp. 324-324
Authors:
SHENOY M
GOLUSZKO E
CHRISTADOSS P
Citation: M. Shenoy et al., THE PATHOGENIC ROLE OF ACETYLCHOLINE-RECEPTOR ALPHA-CHAIN EPITOPE WITHIN ALPHA-146-162 IN THE DEVELOPMENT OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS IN C57BL6 MICE, Clinical immunology and immunopathology, 73(3), 1994, pp. 338-343
Authors:
SHENOY M
KAUL R
GOLUSZKO E
DAVID C
CHRISTADOSS P
Citation: M. Shenoy et al., EFFECT OF MHC CLASS-I AND CD8 CELL-DEFICIENCY ON EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS PATHOGENESIS, The Journal of immunology, 153(11), 1994, pp. 5330-5335
Authors:
KAUL R
SHENOY M
GOLUSZKO E
CHRISTADOSS P
Citation: R. Kaul et al., MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENE DISRUPTION PREVENTS EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS, The Journal of immunology, 152(6), 1994, pp. 3152-3157
Authors:
SHENOY M
GOLUSZKO E
CHRISTADOSS P
Citation: M. Shenoy et al., THE PATHOGENIC ROLE OF ACETYLCHOLINE-RECEPTOR ALPHA-CHAIN PEPTIDE ALPHA-46-162 IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS, The Journal of immunology, 150(8), 1993, pp. 161-161
Authors:
GOLUSZKO E
ROGERS D
KAUL R
SHENOY M
CHRISTADOSS P
Citation: E. Goluszko et al., T-CELL RECEPTOR V-BETA-6 CELLS IMPLICATED IN AUTOIMMUNE MYASTHENIA-GRAVIS MAY NOT BE THE EFFECTOR-CELLS IN B6 MICE, The Journal of immunology, 150(8), 1993, pp. 161-161
Authors:
CHRISTADOSS P
DAVID CS
SHENOY M
GOLUSZKO E
Citation: P. Christadoss et al., GENOMIC DELETION OF T-CELL RECEPTOR V-BETA GENES IN V-BETA-C MUTANT MICE AUGMENTS DEVELOPMENT OF AUTOIMMUNE MYASTHENIA-GRAVIS, The Journal of immunology, 150(8), 1993, pp. 161-161
Authors:
KAUL R
SHENOY M
GOLUSZKO E
CHRISTADOSS P
Citation: R. Kaul et al., POSSIBLE IMMUNOLOGICAL MECHANISMS INVOLVED IN THE RESISTANCE TO THE DEVELOPMENT OF MYASTHENIA-GRAVIS IN THE BM12 STRAIN, The Journal of immunology, 150(8), 1993, pp. 164-164
Risultati:
1-21
|